SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-017200
Filing Date
2019-06-17
Accepted
2019-06-17 17:00:30
Documents
1
Period of Report
2019-06-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4126
  Complete submission text file 0000899243-19-017200.txt   5602
Mailing Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2
Business Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2 (872) 225-6077
Iterum Therapeutics plc (Issuer) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 20 BERKELEY SQUARE, MAYFAIR LONDON X0 W1J 6EQ
Business Address
Chin Mark (Reporting) CIK: 0001734389 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38503 | Film No.: 19901963